BCAA Detection and Analysis

Three amino acids, three keto acids, and the ratio between them is the information.

What to Measure

AnalyteWhy it mattersTypical range in medium
LeucinemTORC1 signalling; ketogenic carbon0.4–0.8 mM
IsoleucineMixed ketogenic and anaplerotic0.4–0.8 mM
ValineAnaplerotic0.4–0.8 mM
α-Ketoisocaproate (KIC)Leucine transamination productLow micromolar
α-Keto-β-methylvalerate (KMV)Isoleucine productLow micromolar
α-Ketoisovalerate (KIV)Valine productLow micromolar

Important distinction. The BCAAs and their keto acids are two halves of a reversible reaction. BCAA concentration alone reflects supply and uptake as much as catabolism; the keto acid concentration reflects the transamination equilibrium. Only measuring both, and ideally the flux between them, distinguishes transfer from catabolism.

Part 1 — Methods

MethodAnalytesSensitivityNote
LC-MS/MS with derivatisation (AQC, dansyl, FMOC)Amino acidsHighDerivatisation improves retention and ionisation
LC-MS/MS without derivatisation, HILIC or ion-pairingAmino acidsModerateSimpler; matrix effects
LC-MS of keto acids with derivatisation (PFBHA, aniline)BCKAsHighKeto acids are poorly ionised without derivatisation
GC-MSAmino acids and keto acidsHighRequires derivatisation; good precision
Enzymatic assaysLeucine or total BCAALow specificitySuitable for screening only
NMRAbundant metabolitesModerateNo derivatisation; lower sensitivity

Readout note. The keto acids are the harder measurement and the more informative one. A BCAA panel without keto acids describes supply; a panel with keto acids describes where the transamination equilibrium sits, and that is what a catabolism claim needs.

Part 2 — Sampling

StepRequirementConsequence if omitted
Medium samplingFixed volume and timepointUptake cannot be computed
Immediate quenchCold, or acidifiedContinued transamination and catabolism
Cell separationBrief spin, coldLeakage from damaged cells
Storage−80 °C; keto acids are less stable than amino acidsDecarboxylation
Derivatisation timingConsistent across samplesBatch effects
Internal standardsIsotope-labelled leucine, isoleucine, valine, and keto acid analoguesRecovery and matrix correction

Caveat on keto acid stability. BCKAs decarboxylate and are volatile in acidic solution. Storage at −80 °C, avoidance of strong acid, and derivative formation soon after extraction reduce the loss. A keto acid value that drifts between runs is usually a handling problem rather than a biological one.

Part 3 — Normalisation and Interpretation

BasisAppropriate whenCaveat
Concentration in mediumUptake or releaseRequires volume and time
Per cell numberComparing conditionsCounting at low numbers
Per mg proteinRoutineProtein changes with treatment
Ratio of BCAA to BCKACatabolic equilibriumBoth measurements must be from the same sample

Important distinction. In culture, the BCAA concentration is usually several-fold above plasma. A fall in medium BCAA therefore reports a large absolute consumption against a large baseline, and a "50% depletion" in culture may be a smaller change than the same percentage in plasma. Reporting absolute concentrations, not only percentages, keeps the comparison honest.

Part 4 — What the Data Can Support

ClaimRequiresNot sufficient
"BCAA consumption increased"Medium depletion with volume, time and cell numberTransporter expression
"Catabolism increased"BCKA production or ¹³C-leucine oxidationBCAA depletion
"Transamination increased"BCAA to BCKA ratio shiftBCAA concentration
"mTORC1 was activated by leucine"Dose–response plus a leucine-insensitive controlCorrelation with proliferation
"BCAA contribute to anaplerosis"¹³C labelling into succinate or malate from valineTotal BCAA consumption

Part 5 — Common Failures

  • • Total BCAA reported as one number.
  • • Keto acids not measured, so catabolism is inferred rather than measured.
  • • BCAA depletion reported as catabolism, when uptake or dilution also changed.
  • • No internal standards, so recovery is unknown.
  • • Keto acid samples stored in acid and shipped, so values fall.
  • • Culture concentrations treated as physiological.
  • • Leucine effects attributed to catabolism, when the mTORC1 route explains them.
  • • Normalisation to protein in treatments that change protein content.

Part 6 — Where This Article Connects

This is the analytical companion to the BCAA article, which covers BCAT, BCKDH and the three carbon fates. It connects to the glutaminolysis article through α-ketoglutarate, which BCAT consumes, and to the nucleotide article through the anaplerotic contribution of valine and isoleucine.

If you need BCAA and BCKA measured in the same sample with isotope standards, we can scope the analysis with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

BCAA and BCKA concentrations, recovery and stability vary by matrix, derivatisation and storage. Method validation is required for each analyte class.

A BCAA concentration does not establish catabolic flux, and a keto acid change does not establish the direction of net transamination without flux data.

Scientific interpretation and experimental design

  • • Three amino acids, three fates. Report separately.
  • • Keto acids carry the information. Measure them.
  • • Keto acids are unstable. Cold, neutral, frozen.
  • • Absolute values, not only percentages.
  • • Uptake is not catabolism.
  • • Signalling is not catabolism.

Selected references for further reading

  • • Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annual Review of Physiology. 2019;81:139–164.
  • • Newgard CB, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism. 2009;9:311–326.
  • • White PJ, et al. The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metabolism. 2018;27:1281–1293.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: